United States ex rel. Lisitza v. Par Pharmaceutical Companies, Inc.

MEMORANDUM OPINION AND ORDER

John J. Tharp, Jr., United States. District Judge ¡

' In this qui tam action brought primarily under the federal False Claims Act and parallel state statutes, the plaintiffs—the United States, the State of Michigan, and the State of Indiana—allege that defendant Par Pharmaceutical Companies, Inc., caused national pharmacy chains to submit false claims for reimbursement from Medicaid by inducing them to fill prescriptions not with the generic drugs originally prescribed but with more expensive forms and dosages of those drugs manufactured by Par. The plaintiffs…